Additional Information

Description

Labetalol HCl Injection, available in a multidose vial format with a concentration of 5 mg/mL and a total volume of 40 mL, is a valuable medication used primarily to manage hypertension in hospital settings. This formulation combines both alpha- and beta-adrenergic blocking properties, making it effective for lowering blood pressure by reducing peripheral vascular resistance and heart rate.

Its multidose vial presentation allows healthcare providers to administer precise doses tailored to individual patient needs, ensuring optimal control of blood pressure levels.The medication is typically administered intravenously, providing rapid onset of action suitable for acute hypertensive episodes or severe hypertension requiring immediate intervention.

Labetalol's dual mechanism of action provides a balanced approach to blood pressure control, minimizing the risk of reflex tachycardia often associated with other antihypertensive medications.

Each 40 mL multidose vial is designed for repeated use within a specified timeframe, adhering to strict aseptic techniques to maintain sterility and prevent contamination. This ensures patient safety and efficacy throughout the treatment course.